Term
|
Definition
| Name assigned by the manufacturer who first develops a drug; it is often derived from the chemical name |
|
|
Term
|
Definition
| Name by which a drug is identified in official publications |
|
|
Term
|
Definition
| Drug name selected and trademarked by the company marketing the drug; also called brand name or proprietary name |
|
|
Term
|
Definition
| Movement of drug molecules in the body in relation to the drug's absorption, distribution, metabolism, and excretion |
|
|
Term
|
Definition
| Process by which drugs are transferred from the site of entry into the body to the bloodstream |
|
|
Term
|
Definition
| Dynamic that achieves the desired therapeutic effect of the drug without causing other undesirable effects |
|
|
Term
|
Definition
| Movement of drugs by the circulatory system to the site of action |
|
|
Term
|
Definition
| Breakdown of a drug to an inscribe form; also referred to as biotransformation. Chemical changes in the body by which energy is provided |
|
|
Term
|
Definition
| Removal of a drug from the body |
|
|
Term
|
Definition
| The process by which drugs alter cell physiology and effect the body |
|
|
Term
|
Definition
| Undesirable effects other than the intended therapeutic effect of a drug |
|
|
Term
|
Definition
| An immune system response that occurs when the body interprets the administered drug as a foreign substance and forms antibodies against the drug |
|
|
Term
| Anaphylactic reaction (anaphylaxis) |
|
Definition
| Severe reaction occurring immediately after exposure to a drug; characterized by respiratory distress and vascular collapse |
|
|
Term
|
Definition
| Occurs when the body becomes accustomed to the effects of a particular drug over a period of time |
|
|
Term
| Toxic effects (toxicities) |
|
Definition
| Specific groups of symptoms related to drug therapy that carry risk for permanent damage or death |
|
|
Term
|
Definition
| Condition that occurs when the body cannot metabolize a drug before additional doses are administered |
|
|
Term
| Idiosyncratic effect (paradoxical effect) |
|
Definition
| Any unusual or peculiar response to a drug that may manifest itself by over response, under response, or even the opposite of the expected response |
|
|
Term
|
Definition
| Combined effect of two or more drugs that produces less than the effect of each drug alone |
|
|
Term
|
Definition
| Combined effect of two or more drugs is greater than the effect of each drug alone |
|
|
Term
|
Definition
| Known to have potential to cause developmental defects in the embryo or fetus |
|
|
Term
|
Definition
| The concentration of drug in the blood serum that produces the desired effect without causing toxicity |
|
|
Term
|
Definition
| Highest plasma concentration of a drug |
|
|
Term
|
Definition
| The point when a drug is at it's lowest concentration |
|
|
Term
|
Definition
| The amount of time it takes for 50% of the blood concentration of a drug to be eliminated from the body |
|
|
Term
|
Definition
| Single order carried out immediately |
|
|
Term
|
Definition
| Computerized automated dispensing cabinets |
|
|
Term
|
Definition
| bar-code medication administration |
|
|
Term
|
Definition
| outside the intestines or alimentary canal |
|
|
Term
|
Definition
| a glass flask that contains a single dose of medication for parenteral administration |
|
|
Term
|
Definition
| a glass bottle with a self-sealing stopper through which the medication is removed |
|
|
Term
|
Definition
| are administered into the dermis, just below the epidermis |
|
|
Term
|
Definition
| are administered into the adipose tissue layer just below the epidermis and dermis |
|
|
Term
|
Definition
| deliver medication through the skin and subcutaneous tissues into certain muscles |
|
|
Term
|
Definition
| technique used to administer medications intramuscularly that insures the medication does not leak back along the needle track and into the subcutaneous tissue, reducing pain and discomfort |
|
|
Term
|
Definition
| injection of solution into the vein |
|
|
Term
| piggyback delivery system |
|
Definition
| intermittent IV administration of medications through a primary IV line, with the additive container positioned higher than the primary IV solution |
|
|
Term
| volume-control administration set |
|
Definition
| intermittent intravenous medication infusion diluted with a small amount of solution |
|
|
Term
|
Definition
| battery-operated pump for intermittent infusion allowing medication mixed in a syringe to be connected to the primary line and delivered by mechanical pressure applied to the syringe plunger |
|
|
Term
|
Definition
| central venous access device |
|
|
Term
|
Definition
| application of a substance directly to a body surface |
|
|
Term
|
Definition
| administration of a drug in solution via the respiratory tract |
|
|
Term
|
Definition
|
|
Term
|
Definition
| superficial layer of the skin |
|
|
Term
|
Definition
| piece of gauze or other material used to cover a wound |
|
|
Term
|
Definition
| removal of devitalized tissue and foreign material |
|
|
Term
|
Definition
| separation of the layers of a surgical wound; may be partial, superficial, or a complete disruption of the surgical wound |
|
|
Term
|
Definition
| layer of skin below the epidermis |
|
|
Term
|
Definition
| dehydration; the process of being rendered free from moisture |
|
|
Term
|
Definition
| protective covering placed over a wound |
|
|
Term
|
Definition
| a thick, leathery scab or dry crust that is necrotic and must be removed for adequate healing to occur |
|
|
Term
|
Definition
| protrusion of viscera through an incision |
|
|
Term
|
Definition
| fluid that accumulates in a wound; may contain serum, cellular debris, bacteria, and white blood cells |
|
|
Term
|
Definition
| an abnormal passage from an internal organ to the skin or from one internal organ to another |
|
|
Term
|
Definition
| occurs when two surfaces rub against each other; the resulting injury resembles an abrasion and can also damage superficial blood vessels directly under the skin |
|
|
Term
|
Definition
| new tissue that is pink/red in color and composed of fibroblasts and small blood vessels that fill an open wound when it starts to heal |
|
|
Term
|
Definition
| deficiency of blood in a particular area |
|
|
Term
|
Definition
| softening through liquid; overhydration |
|
|
Term
|
Definition
| death of cells and tissue |
|
|
Term
| negative-pressure wound therapy (NPWT) |
|
Definition
| activity that promotes wound healing and wound closure through the application of uniform negative pressure on the wound bed, reduction in bacteria in the wound, and the removal of excess wound fluid |
|
|
Term
|
Definition
| any lesion caused by unrelieved pressure that results in damage to underlying tissue |
|
|
Term
|
Definition
| comprised of white blood cells, liquefied dead tissue debris, and both dead and live bacteria |
|
|
Term
|
Definition
| containing or mixed with blood |
|
|
Term
|
Definition
| connective tissue that fills a wound area |
|
|
Term
|
Definition
| mixture of serum and red blood cells |
|
|
Term
|
Definition
| composed of clear, serous portion of the blood from serous membranes |
|
|
Term
|
Definition
| underlying layer that anchors the skin layers to the underlying tissues of the body |
|
|
Term
|
Definition
| injury that results in a disruption in the normal continuity of a body tissue |
|
|
Term
|
Definition
|
|
